Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

[1]  E. Bosmans,et al.  Indicators of immune activation in major depression , 1996, Psychiatry Research.

[2]  Abraham Weizman,et al.  Antinuclear autoantibodies in chronic schizophrenia , 1995, Acta psychiatrica Scandinavica.

[3]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[4]  J. Rybakowski,et al.  Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine , 1995, Annals of the New York Academy of Sciences.

[5]  V. Arolt,et al.  Cytokine Production and Serum Proteins in Depression , 1995, Scandinavian journal of immunology.

[6]  J. Amsterdam,et al.  Acute phase proteins in affective illness , 1995, Biological Psychiatry.

[7]  J. Calabrese,et al.  Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. , 1995, Journal of psychiatric research.

[8]  R. Derijk,et al.  Induction of plasma interleukin-6 by circulating adrenaline in the rat , 1994, Psychoneuroendocrinology.

[9]  B. Leonard,et al.  Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.

[10]  R. Rimón,et al.  Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders , 1994, Schizophrenia Research.

[11]  J. Timmer,et al.  Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle , 1994, The clinical investigator.

[12]  T P Stein,et al.  Excretion of IL-6 by astronauts during spaceflight. , 1994, The American journal of physiology.

[13]  P. Blockx,et al.  Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic–pituitary–adrenal axis in depression , 1994, Psychological Medicine.

[14]  G. Hemmings,et al.  Changes of Plasma Concentrations of Interleukin-1α and Interleukin-6 with Neuroleptic Treatment for Schizophrenia , 1994, British Journal of Psychiatry.

[15]  A. Malik,et al.  Thrombin receptor activation peptide induces pulmonary vasoconstriction. , 1994, The American journal of physiology.

[16]  B. Rabin,et al.  Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness , 1994, Psychiatry Research.

[17]  P. Black,et al.  Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences , 1994, Antimicrobial Agents and Chemotherapy.

[18]  B. Rabin,et al.  Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. , 1993, Endocrinology.

[19]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[21]  F. Aloisi,et al.  Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα , 1993, Journal of Neuroimmunology.

[22]  E. Benveniste,et al.  Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine , 1993, Journal of Neuroimmunology.

[23]  J. Bauer,et al.  Participation of interleukin-6 in the pathogenesis of alzheimer's disease , 1992, Neurochemistry International.

[24]  P. Joyce,et al.  Elevated levels of acute phase plasma proteins in major depression , 1992, Biological Psychiatry.

[25]  I. Kushner.  The acute phase response: from Hippocrates to cytokine biology. , 1991, European cytokine network.

[26]  A. Vander,et al.  The effects of psychological stress on plasma interleukin-6 activity in rats , 1990, Physiology & Behavior.

[27]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[28]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[29]  N. Müller.  Die Rolle des Zytokinnetzwerks im ZNS und psychische Störungen , 1997, Der Nervenarzt.

[30]  V. Barak,et al.  Changes in Interleukin-1β and Soluble Interleukin-2 Receptor Levels in CSF and Serum of Schizophrenic Patients , 1995, Journal of basic and clinical physiology and pharmacology.

[31]  H. Meltzer,et al.  Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. , 1994, Neuropsychobiology.

[32]  S. Kanba,et al.  Serum interleukin-6 in schizophrenic patients. , 1991, Life sciences.

[33]  Robert L. Spitzer,et al.  User's guide for the Structured clinical interview for DSM-III-R : SCID , 1990 .

[34]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.